Proceeds will enable Xilis to build its capabilities in supporting biopharma collaborations for drug discovery Extension led by new investor FPV Ventures Xilis, Inc., a pioneering biotechnology
National public-private consortium aims to bring together researchers, oncologists, knowledge institutes and the business community to collaboratively develop better and affordable cancer medicines more quicklyDURHAM, N.C. (BUSINESS WIRE) Xilis, Inc., a pioneering company developing its MicroOrganoSphere™ (MOS) te.
MARLBOROUGH, Mass., April 19, 2022 Akoya Biosciences, Inc., The Spatial Biology Company®, today announced the appointment of Dr. Ehab A. El-Gabry as the company’s Chief Medical. | April 19, 2022
MARLBOROUGH, Mass., April 14, 2022 Akoya Biosciences, Inc. , The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2022 after the. | April 14, 2022